Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Alaunos Therapeutics Inc TCRT

Healthcare Biotechnology
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops small molecules to treat obesity and other metabolic disorders. The company develops an oral obesity compound that addresses shortcomings of injectable GLP-1 receptor agonists, including preserving lean muscle mass. It also evaluates ALN1001 and related derivatives on lipid deposition and gene... see more

Current News (NDAQ:TCRT)

Alaunos Therapeutics Announces $2.0 Million Registered Direct Offering

GlobeNewswire June 23, 2025

PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies

GlobeNewswire June 18, 2025

PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), To File Schedule 13D Reporting 5.09% Stake in Alaunos Therapeutics, Inc. (Nasdaq: TCRT)

GlobeNewswire May 14, 2025

Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives

GlobeNewswire November 14, 2023

Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives

GlobeNewswire August 14, 2023

Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic Malignancies

GlobeNewswire June 29, 2023

Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual Meeting

GlobeNewswire May 25, 2023

Alaunos Therapeutics Reports First Quarter 2023 Financial Results

GlobeNewswire May 10, 2023

Alaunos Therapeutics to Report First Quarter 2023 Financial Results on May 10, 2023

GlobeNewswire May 3, 2023
View More News ››

Opinion & Analysis (NDAQ:TCRT)

Investment in cell and gene therapies ramps up

The Life Sciences Report June 8, 2016
View More Opinion ››

Bullboard Posts (NDAQ:TCRT)

Buy buddy buy.

Otherwise FOMO for you fellas out there today anyway
coolfooldumbguy - October 9, 2025

Buy buddy buy

Because it's going up this morning
coolfooldumbguy - April 2, 2025

Alaunos Therapeutics (TCRT): A Transformative Journey in Imm

Interesting play here. TCRT looks like it's in survival mode right now. Cash is super tight at $1.70M and they've burned through...
MikeTester - January 24, 2025

ZIOP - PLAYS FOR TUESDAY

<< View Post To Watch Video >>
HDavis - September 5, 2021

ziop on the rise

kiop has 4 buyes and 1 sell. the target prise is $6.50 a double from here.
artjoy4 - June 4, 2020

Saved again On ZIOP

I was saved again by the chief.  He told me that ziop was looking weak so i took his advice and sold.  Lucky i did because i...
stockracer1 - November 29, 2010
View more Bullboard ››

Atlas Salt Inc.

Atlas Salt Inc.

Atlas Salt Inc. engages in the evaluation and exploration of mineral properties in Newfoundland and Labrador, Canada. The ...
View More »

Podcasts